A global leader in biological reference materials, long relied upon by researchers worldwide, reached a point where paper-based processes were holding it back. Massive volumes of records across manufacturing, QC, biorepository management, and genomics labs slowed teams down, increased the risk of human error, and limited the organization’s ability to scale.
The organization selected L7|ESP® as a unified platform to replace fragmented, manual practices with configurable digital workflows. It started by adopting L7 LIMS to digitalize core lab processes and automate tasks such as inventory management and results reporting. As the team’s expertise grew, it used L7|ESP’s low-code framework to design and refine workflows that fit its science, becoming true Citizen Developers™ of its own solutions.
Executive leadership then expanded the transformation with L7 MES to digitalize batch records, centralize quality control, and gain better batch visibility. By bringing LIMS and MES together in a single L7|ESP instance, the organization eliminated operational silos and established a flexible, contextualized data foundation that supports scientific innovation today and prepares the organization for AI and advanced analytics in the future.
To access this resource, please make sure to accept cookies.